Drugs / [18F]-FEOBV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03998852 | Apr 2021 → Apr 2027 expected | — | University Hospital, Bordeaux | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]-FEOBV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03998852 ↗ |
| Modality | Diagnostic / imaging agent | “Positron Emission Tomography (PET) molecular imaging of dopaminergic and cholinergic systems” NCT03998852 ↗ |